Canada markets closed

Mereo BioPharma Group plc (MREO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.78000.0000 (0.00%)
At close: 04:00PM EDT
2.7900 +0.01 (+0.36%)
After hours: 05:16PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
7,128
10,000
0
49,213
0
Cost of Revenue
1,871
2,574
-1,146
24,169
0
Gross Profit
5,257
7,426
1,146
25,044
0
Operating Expenses
Research Development
19,538
17,418
29,465
31,796
22,278
Selling General and Administrative
20,251
18,424
26,107
21,504
28,922
Total Operating Expenses
39,789
34,562
53,844
53,300
51,200
Operating Income or Loss
-34,532
-27,136
-52,698
-28,256
-51,200
Interest Expense
2,955
2,881
4,175
5,400
8,699
Total Other Income/Expenses Net
5,540
-2,112
13,095
52,903
-167,003
Income Before Tax
-28,137
-29,998
-42,938
19,220
-226,842
Income Tax Expense
-2,069
-532
-718
2,046
-3,846
Income from Continuing Operations
-26,068
-29,466
-42,220
17,174
-222,996
Net Income
-26,068
-29,466
-42,220
17,174
-222,996
Net Income available to common shareholders
-26,068
-29,466
-42,220
17,174
-222,996
Basic EPS
-0.25
-
-0.36
0.13
-3.27
Diluted EPS
-0.25
-
-0.36
-0.34
-3.27
Basic Average Shares
124,959
-
113,987
105,564
68,178
Diluted Average Shares
124,959
-
113,987
111,055
68,178